Market Insights Health OTC Pharmaceuticals

Skin Treatment - Netherlands

Netherlands

In the Netherlands, the revenue in the Skin Treatment market market is projected to reach €92.12m in 2024.
It is expected to grow annually by 4.12% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue in this market, amounting to €3,840.00m in 2024.
When considering the total population, per person revenues of €5.21 are generated in the Netherlands in 2024.
The Netherlands is experiencing a growing demand for natural and organic skincare products in the OTC Pharmaceuticals market.

Key regions: Europe, United Kingdom, United States, Canada, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment market in Netherlands has been experiencing significant growth in recent years, driven by changing customer preferences and trends in the market. Customer preferences in the Skin Treatment market in Netherlands have shifted towards more natural and organic products. Consumers are increasingly concerned about the ingredients used in skincare products and are opting for products that are free from harmful chemicals and additives. This preference for natural and organic products is in line with global trends, as consumers become more conscious about the impact of their choices on their health and the environment. In addition to natural and organic products, there is also a growing demand for skincare products that address specific skin concerns. Consumers in Netherlands are looking for products that can effectively treat issues such as acne, aging, and hyperpigmentation. This trend is driven by the desire for personalized skincare solutions that cater to individual needs.Another trend in the Skin Treatment market in Netherlands is the rise of multi-step skincare routines. Inspired by Korean beauty trends, consumers are adopting elaborate skincare routines that involve multiple products and steps. This trend has led to an increased demand for skincare products such as cleansers, toners, serums, moisturizers, and masks. Local special circumstances in Netherlands also contribute to the development of the Skin Treatment market. The country has a high standard of living and a strong economy, which allows consumers to spend more on skincare products. Additionally, Netherlands has a well-developed retail infrastructure, with a wide range of distribution channels available for skincare products, including pharmacies, department stores, specialty beauty stores, and online platforms. This accessibility to skincare products further fuels the growth of the market.Underlying macroeconomic factors also play a role in the development of the Skin Treatment market in Netherlands. The country has a stable economy and a high disposable income, which enables consumers to invest in skincare products. Furthermore, the aging population in Netherlands contributes to the growth of the market, as older consumers are more likely to prioritize skincare and anti-aging products.In conclusion, the Skin Treatment market in Netherlands is experiencing growth due to changing customer preferences, including a preference for natural and organic products, a demand for skincare products that address specific skin concerns, and the adoption of multi-step skincare routines. Local special circumstances, such as a high standard of living and a well-developed retail infrastructure, also contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as a stable economy and an aging population, further drive the development of the Skin Treatment market in Netherlands.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.